Intrinsic Value of S&P & Nasdaq Contact Us

Kestra Medical Technologies, Ltd. KMTS NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
49/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$28.00
+41.8%

Stock Statistics — KMTS

Kestra Medical Technologies, Ltd. (KMTS) has a market capitalization of $1.15B and trades at $19.74. The 52-week range is 13.25-30.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -3.8, Earnings Per Share (EPS) of $-5.13, annual revenue of $59.82M.

The stock has a beta of 0.17, operates in the Healthcare sector.

Trading Data
Current Price$19.74
52-Week Range13.25-30
Volume153.81K
Avg Volume (30D)352.73K
Market Cap$1.15B
Beta (1Y)0.17
Company
IPO Date2025-03-06
Employees300
CEOBrian Webster
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINBMG524411052
CUSIPG52441105
Income (Latest Year)
Revenue$59.82M
Gross Profit$24.21M
EBITDA$-97.98M
Operating Income$-106.38M
Net Income$-113.81M
EPS$-5.13
EPS Diluted$-5.13
Shares Outstanding$49.53M
Balance Sheet (Latest Year)
Total Assets$295.74M
Current Assets$255.33M
Cash & ST Investments$237.6M
Total Liabilities$90.34M
Total Debt$44.31M
Net Debt$-193.28M
Total Equity$205.41M
Debt / Equity0.22
Valuation Ratios
P/E Ratio-3.8
P/S Ratio19.26
P/B Ratio5.61
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message